Androgen deprivation therapy for prostate cancer and the risk of autoimmune diseases

被引：0
作者：
Jui-Ming Liu
Cheng-Ping Yu
Heng-Chang Chuang
Chun-Te Wu
Ren-Jun Hsu
机构：
[1] Ministry of Health and Welfare,Division of Urology, Department of Surgery, Taoyuan General Hospital
[2] National Yang-Ming University,Faculty of Medicine
[3] National Defense Medical Center,Graduate Institute of Life Sciences
[4] National Defense Medical Center,Department of Pathology and Graduate Institute of Pathology and Parasitology, Tri
[5] Chang Gung Memorial Hospital,Service General Hospital
[6] Tzu Chi University,Department of Urology
来源：
Prostate Cancer and Prostatic Diseases | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：475 / 482
页数：7
相关论文
共 50 条
  • [41] Effect of androgen deprivation therapy on cardiovascular risk factors in prostate cancer
    Roayaei, Mahnaz
    Ghasemi, Sedighe
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2013, 18 (07): : 579 - 581
  • [42] Risk of dementia following androgen deprivation therapy for treatment of prostate cancer
    Anna Krasnova
    Matthew Epstein
    Maya Marchese
    Barbra A. Dickerman
    Alexander P. Cole
    Stuart R. Lipsitz
    Paul L. Nguyen
    Adam S. Kibel
    Toni K. Choueiri
    Shehzad Basaria
    Lorelei A. Mucci
    Maxine Sun
    Quoc-Dien Trinh
    Prostate Cancer and Prostatic Diseases, 2020, 23 : 410 - 418
  • [43] RISK OF DEMENTIA FOLLOWING ANDROGEN DEPRIVATION THERAPY FOR TREATMENT OF PROSTATE CANCER
    Krasnova, Anna
    Tully, Karl Heinrich
    Epstein, Matthew
    Marchese, Maya
    Dickermann, Barbra A.
    Cole, Alexander Putnam
    Lipsitz, Stuart R.
    Nguyen, Paul L.
    Kibel, Adam S.
    Choueiri, Toni K.
    Basaria, Shehzad Sultan
    Mucci, Lorelei A.
    Sun, Maxine
    Quoc-Dien Trinh
    JOURNAL OF UROLOGY, 2019, 201 (04) : E564 - E564
  • [44] Radiation Therapy and Androgen Deprivation in the Management of High Risk Prostate Cancer
    Dal Pra, Alan
    Cury, Fabio L.
    Souhami, Luis
    INTERNATIONAL BRAZ J UROL, 2011, 37 (02): : 161 - 175
  • [45] Risk of dementia following androgen deprivation therapy for treatment of prostate cancer
    Krasnova, Anna
    Epstein, Matthew
    Marchese, Maya
    Dickerman, Barbra A.
    Cole, Alexander P.
    Lipsitz, Stuart R.
    Nguyen, Paul L.
    Kibel, Adam S.
    Choueiri, Toni K.
    Basaria, Shehzad
    Mucci, Lorelei A.
    Sun, Maxine
    Trinh, Quoc-Dien
    PROSTATE CANCER AND PROSTATIC DISEASES, 2020, 23 (03) : 410 - 418
  • [46] Androgen-Deprivation Therapy and the Risk of Stroke in Patients With Prostate Cancer
    Azoulay, Laurent
    Yin, Hui
    Benayoun, Serge
    Renoux, Christel
    Boivin, Jean-Francois
    Suissa, Samy
    EUROPEAN UROLOGY, 2011, 60 (06) : 1244 - 1250
  • [47] Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality
    Tsai, Henry K.
    D'Annico, Anthony V.
    Sadetsky, Natalia
    Chen, Ming-Hui
    Carroll, Peter R.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (20) : 1516 - 1524
  • [48] Radiotherapy with or without androgen deprivation therapy in intermediate risk prostate cancer?
    Amit, Uri
    Lawrence, Yaacov R.
    Weiss, Ilana
    Symon, Zvi
    RADIATION ONCOLOGY, 2019, 14 (1)
  • [49] Cardiovascullar risk with androgen deprivation therapy for prostate cancer: Potential mechanisms
    Tivesten, Asa
    Pinthus, Jehonathan H.
    Clarke, Noel
    Duivenvoorden, Wilhelmina
    Nilsson, Jan
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (11) : 464 - 475
  • [50] miRNAs and androgen deprivation therapy for prostate cancer
    Konoshenko, Maria Yu
    Bryzgunova, Olga E.
    Laktionov, Pavel P.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2021, 1876 (02):
12345